{"pageContent": "Background: It remains unclear whether adding long-term prostate-specific antigen velocity (PSAV) to baseline PSA values improves classification of prostate cancer (PCa) risk and mortality in the general population.", "metaData": {"source": "Variation in Radiotherapy Referral and Treatment for High-risk Pathological Features after Radical Prostatectomy: Results from a Population-based Study\nhttps://pubmed.ncbi.nlm.nih.gov/29103854/"}}